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Cardiomyocytes may experience significant cell swelling during ischemia and reperfusion. Such changes in cardiomyocyte volume have been
shown to affect the electrical properties of the heart, possibly leading to cardiac arrhythmia. In the present study the regulatory volume decrease
(RVD) response of neonatal rat cardiomyocytes was studied in intact single cells attached to coverslips, i.e. with an intact cytoskeleton. The
potential contribution of KCNQ (Kv7) channels to the RVD response and the possible involvement of the F-actin cytoskeleton were investigated.
The rate of RVD was significantly inhibited in the presence of the KCNQ channel blocker XE-991 (10 and 100 μM). Electrophysiological
experiments confirmed the presence of an XE-991 sensitive current and Western blotting analysis revealed that KCNQ1 channel protein was
present in the neonatal rat cardiomyocytes. Hypoosmotic cell swelling changes the structure of the F-actin cytoskeleton, leading to a more rounded
cell shape, less pronounced F-actin stress fibers and patches of actin. In the presence of cytochalasin D (1 μM), a potent inhibitor of actin
polymerization, the RVD response was strongly reduced, confirming a possible role for an intact F-actin cytoskeleton in linking cell swelling to
activation of ion transport in neonatal rat cardiomyocytes.
© 2007 Elsevier B.V. All rights reserved.Keywords: KCNQ1; Kv7.1; Cell swelling; Ischemia; Arrhythmia1. Introduction
Cardiac cells may experience significant swelling during the
course of ischemia and reperfusion [1], and such changes in cell
volume may seriously affect cardiac function. Swelling of
cardiac myocytes has been shown to present a major threat to
the heart both acutely by promoting the development of fatal
arrhythmias [2] and long term by increasing infarct size due to
accelerated necrosis [3]. The pro-arrhythmic effect of swelling
is mainly due to alterations in the electrophysiological proper-
ties of the cardiomyocytes. Several ion channels have been
reported to change their activity during swelling, among these
K+, Ca2+, and non-selective cation channels (for review see⁎ Corresponding author. Department of Biomedical Sciences, The Panum
Institute, University of Copenhagen, Blegdamsvej 3, 12.5, DK-2200 Copenha-
gen N, Denmark. Tel.: +45 35327134; fax: +45 35327555.
E-mail address: kirstinec@mfi.ku.dk (K. Calloe).
0167-4889/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamcr.2007.02.008[2,4]). Most cells are able to counteract cell swelling through
activation of regulatory volume decrease (RVD) responses. The
early part of the RVD response after cell swelling is in many cell
types dominated by a loss of KCl and water, often through
activation of K+ and Cl− channels [5]. This loss of osmolytes
leads to a reduction of cell volume that may rescue cells from
damage, membrane permeabilization and cell rupture.
In cardiomyocytes it has been shown that delayed rectifier K+
current was increased in cardiomyocytes exposed to hypotonic
solution [6]. A subsequent study demonstrated that the rapid and
slow delayed rectifier K+ currents (IKr and IKs, respectively)
responded differently to hypotonic challenges. Patch-clamp
experiments revealed that IKr was reduced whereas the IKs
current was activated during cell swelling [7]. In cardiomyo-
cytes, the IKs current is most likely mediated by the KCNQ1
potassium channel (KV7.1) in a complex with the accessory
β-subunit KCNE1 [8,9]. Biophysically the increase in KCNQ1
mediated current upon swelling has been well characterized in
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including adult cardiomyocytes [7,12]. This increase in KCNQ1
current during cell swelling has been shown to be important for
the RVD response (measured as a change in cell size) in
transfected cells [11], a role for the KCNQ1/KCNE1 complex
has been suggested in the RVD response of murine tracheal
epithelial cells [14] and activation of KCNQ1 channels has been
shown to be implicated in secretion-associated shrinkage in
rabbit parietal cells [15]. However, the effect of activating
KCNQ1 channels on actual cell size has to our knowledge not
previously been investigated in cardiomyocytes. This prompted
us to establish the relative importance of KCNQ channels in the
RVD response of neonatal rat cardiomyocytes. Changes in cell
volume have been linked to changes in the structure of the F-actin
cytoskeleton [16–20], and these changes in the cytoskeletal
structure may initiate swelling-activated pathways for both Cl−
[21] and K+ [10,16,22] channels, including the KCNQ channels
[10]. Thus, to maintain the actin cytoskeleton as intact as
possible, neonatal rat cardiomyocytes attached to coverslip were
used in all experiments and we aimed to investigate whether
changes in organization of the F-actin cytoskeleton play a role in
regulating the RVD response of neonatal rat cardiomyocytes.
2. Materials and methods
2.1. Preparation of primary culture of neonatal rat cardiomyocytes
Ventricular myocytes were isolated by a method modified from Simpson and
Savion [23]. Briefly, 1–2 litters (15–20 animals) of neonatal Wistar rats (1–2
days old) were used for each preparation. The hearts were excised aseptically and
the ventricles cut into 4–6 pieces. The tissue was incubated for 15 min in T&D
(Trypsin and DNase: Hanks' balanced salt solution (HBSS, Invitrogen, cat. no.
14180-046, Carlsbad, CA, USA) supplemented with (in mM): glucose 5.6;
MgSO4 0.8; 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) (HEPES) 20;
penicillin 100 units/mL; streptomycin 100 μg/mL (Invitrogen, Carlsbad, CA,
USA); DNase I 0.02mg/mL; Trypsin (BDDifco, cat. no. 215240, Franklin Lakes,
NJ, USA) 1.5 mg/mL; Heparin (10 IE/mL); pH adjusted to 7.4 medium at 37 °C
with slow shaking. After incubation, the tissue solution was triturated gently and
the supernatant was discarded. Another 10 mLT&D medium was added and the
tissue was incubated for 15 min. After trituration, the supernatant was transferred
to a tube containing 1.4 mL fetal calf serum (FCS, Invitrogen, Carlsbad, CA,
USA). This was repeated 10–12 times with 5 min incubations. DNase was added
to the supernatants and centrifugation was performed for 10 min at 200×g. The
cell pellet was resuspended in minimal essential media (MEM/G) (MEM,
Invitrogen, Carlsbad, CA, USA) supplemented with 5% FCS, Vitamin B12
(0.002 mg/mL), penicillin (100 units/mL), streptomycin (100 μg/mL) and
L-glutamine (2 mM)), and the suspension passed through a 40 mesh cell
strainer (opening size 380 μM). Cells were seeded onto collagen coated
coverslips (100000 cells/cm2). For collagen coating, a solution of collagen type
VI (Sigma-Aldrich, St. Louis, MO, USA), 0.142 mg/mL in 0.1% acetic acid
and 30% ethanol was added to the coverslips and incubated for 3 h at 37 °C.
Excess solution was removed and the coverslips were left to dry on the lab
bench for 2–3 h. Fresh medium was provided each day. The first 3 days
including the day of isolation the medium was MEM/G/B (MEM/G sup-
plemented with 100 μM bromo-deoxyuridine), from day 4 and for the remaining
period MEM/G.
2.2. Cell volume measurements
Neonatal rat cardiomyocytes grown on coverslips were loaded with 5 μM
calcein-AM (Molecular Probes, Leiden, The Netherlands) in Tyrodes Buffer
(TB, in mM: NaCl 136; KCl 4; CaCl2 1.8; MgCl2 0.8; D-glucose 6; HEPES 5;
2-morpholinoethanesulfonic acid (MES) 5; pH 7.3) for 15 min at 37 °C, washedonce and incubated for 30 min at 37 °C to allow de-esterification of the dye. The
coverslips containing cardiomyocytes were placed in an open chamber on the
stage of an inverted microscope and perfused continuously by gravity driven
flow (1 mL/min) at room temperature (approximately 20 °C). Hypoosmotic
exposure was obtained by dilution with HEPES (10 mM) buffered H2O (pH 7.3)
to 0.667 of the normal osmolarity. In some experiments Cytochalasin D (CD,
Sigma-Aldrich, St. Louis, MO, USA) or XE-991 (a gift from NeuroSearch A/S,
Ballerup, Denmark) was included. Concentrated stock solutions of CD and XE-
991 were prepared in dimethyl sulfoxide (DMSO). The final concentration of
DMSO was always kept below 0.1%, a concentration that did not interfere with
the measurements.
Relative changes in cell volume were measured using a confocal microscope
(Leica TCS SP2) equipped with a 63× NA 1.2 objective and an argon laser. After
selection of a region of healthy neonatal rat cardiomyocytes (as determined by
phase contrast, observation of contractile properties and dye loading), the
selected cells were scanned in the x–z direction (side-view/cross-section) with
scans performed and images saved every 20 s for the duration of the experiment.
Changes in relative cell volume were calculated as the cross-sectional area
determined from the area of calcein fluorescence using thresholding (MetaMorph
software, Universal Imaging Corp. Downington, PA, USA) at time t after a
change in osmolarity, relative to the average initial area (isoosmotic, before
perfusion with hypoosmotic TB). The RVD rate was calculated by linear
regression to the linear part of the curve after maximal cell swelling and is given
as relative change per s.
The relative cell volume measured from the cross-sectional area was a linear
function of changes in osmolarity in the range from 0.5 to 1.5 times normal
osmolarity (R=0.97, data not shown). As the major response of the neonatal rat
cardiomyocytes to cell swelling occurred in the form of an increase in cell height,
the underestimation is probably small.
2.3. Electrophysiology
For current-clamp experiments, a discontinuous single-electrode voltage-
clamp (dSEVC) amplifier (NPI electronic, Tamm, Germany) was used.
Switching frequency was 30 kHz with a duty cycle of 1/4, and current and
voltage signals were filtered at 1 kHz using the intrinsic filters of the amplifier.
Data were sampled at 10 kHz using Cellworks software (NPI electronic, Tamm,
Germany), an A to D converter board (PCI1200, National Instruments, Austin,
TX, USA) and an INT-10 breakout box (NPI electronic, Tamm, Germany).
Coverslips with neonatal rat cardiomyocytes were superfused with TB. Patch
pipettes with an average resistance of 3–4 MΩ were filled with a solution
containing (in mM): Na+ 10; K+ 140; Cl− 13.8; gluconate 140; Ca2+ 1.9; Mg2+ 5;
ATP 5; EGTA 5; HEPES 10; pH 7.2. Gigaseals were obtained and the membrane
under the pipette was broken by brief suction. Then the membrane potential was
monitored by zero current-clamp. The monolayer was paced by current injection
through the pipette at 1 Hz. The current was adjusted to 1.5 times the threshold
value. Hypoosmotic swelling was induced as described above. In experiments
with XE-991, the cells were treated for 3 min with the compound before the
hypoosmotic challenge. Since the myocytes were coupled in a functional
syncytium, large injections of current were needed in order to initiate an action
potential. This often distorted the initial part of the action potential and made it
difficult to determine the peak value of the depolarization. Therefore APD was
determined, not as the time to a certain proportion of repolarization, but as
repolarization to the diastolic potential plus 10 mV.
Whole-cell patch-clamp studies were performed at room temperature using
an EPC-9 amplifier (HEKA Electronics, Lambrecht, Germany). Coverslips with
neonatal cardiomyocytes were transferred to the perfusion chamber and
superfused with isoosmotic solution consisting of (in mM) NaCl 100; KCl 4;
CaCl2; MgCl2 1; D-mannitol 100; HEPES 10 (pH 7.4 with NaOH) and
hypoosmotic solution (removal of 50 mM D-mannitol). Pipettes had resistance
between 1.5 and 2.5 MΩ when filled with a solution consisting of (in mM): KCl
144; EGTA 1; HEPES 10 (pH 7.2 with KOH). CaCl2 and MgCl2 were added in
concentrations calculated to give free concentrations of 100 nM and 1 mM
respectively. No zero current or leak current subtraction was performed during
the experiments. Series resistance was between 4 and 10 MΩ and constant
during recordings. Data analysis and drawings were performed using IGOR
software (WaveMetrics, Lake Oswego, OR, USA) or Graphpad Prism software
(GraphPad Software, San Diego California USA).
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(20 °C) and perfusion was maintained at 1 mL/min.
2.4. Reverse transcription PCR (RT-PCR)
Total RNAwas isolated from neonatal rat heart and from primary culture of
neonatal rat cardiomyocytes prepared using the RNeasy mini system (Qiagen
Ltd., West Sussex, England) according to the manufacturer's instruction. The
cardiomyocytes were harvested on day 6 in culture. The RNA was reverse
transcribed using a poly T primer (5′-T24 -V-N-3′) and Superscript™ III
(Invitrogen). Controls were performed in the absence of enzyme. The RT
product was PCR amplified using oligodeoxynucleotides primers (see Table 1)
for rat KCNE1–3 as described by Lan et al. [13], primers for rat KCNE4 was
own design and modified from Radicke et al. [24]. Primers for rat KCNQ1–5 as
described by Rasmussen et al. [25]. A primer set for GAPDH was used for
internal control. The cycling conditions were 2 min at 94 °C; 30 cycles at 94 °C
for 30 s, 50 °C for 1 min, 72 °C for 1 min; 1 cycle at 72 °C for 5 min followed by
4 °C. Amplified products were analyzed using 2% agarose gels.
2.5. Immunoblot analysis
A polyclonal serum was raised against the human KCNQ1 (hKCNQ1)
protein (Genbank accession no. NM_000218) using the sequence
EQLTVPRRGPDEGS (residues 663–676) (Eurogentec, Seraing, Belgium).
The antibody hKCNQ1 was affinity-purified as described in detail previously
[26]. The antibody specificity was verified by omission of the primary antibody
and by blocking experiments with the peptide the antibody was raised against
(not shown).
For preparation of lysates, Chinese Hamster Ovary (CHO), COS-1 cells or
neonatal rat cardiomyocytes were grown to confluency and washed with ice-cold
phosphate-buffered saline (PBS, in mM: NaCl 136; KCl 2.5; KH2PO4 1.5;
NaHPO4 6.5; pH 7.4). In some experiments cells were incubated with CD (1 μM
in PBS for 5 min at room temperature with vertical shaking). The cells were
suspended in modified RIPA buffer (in mM: Tris/HCl 50; NaCl 150; NaF 1;
Na3VO4 1; 0,5%Triton X-100, and protease inhibitors, pH 7,4) and incubated for
3 h at 4 °C with gentle shaking. Lysates were centrifuged at 10,000×g for 15 min
at 4 °C, supernatants were collected, and protein concentration was determined
by Bradford assay. The lysates were not subjected to heat treatment prior to
Western Blot analysis to avoid aggregation and degradation. Non-heat treated
lysates (25 μg/lane) were separated on 7,5% SDS-PAGE polyacrylamide gels
using the Bio-Rad Laboratories minigel system (Hercules, CA, USA). ProteinsTable 1
Primers and conditions for PCR
Gene Accession no. Primer sequence (5′–3′)
rKCNE1 NM_012973 F: GGATGGCCCTGTCCAA
R: CCAGCTTCTTGGATCG
rKCNE2 NM_133603 F: CAGCTGGAGGAGGAAC
R: TGCCAATCCTCCACGA
rKCNE3 NM_022235 F: CAACGGGACTGAGACC
R: TGCGTGAACGGGTATA
rKCNE4 NM_212526 F: AAGAGGCGGGAGAAG
R: GAGCCACCTCCAGAGG
rKCNQ1 NM_032073 F: CACCATCGGGCCACCA
R: GATGGTGTTGCTGCCA
rKCNQ2 NM133322 F: TGAAGATCTTACCCCTG
R: GCCTTTGGTGCGGTCC
rKCNQ3 NM031597 F: GACATGATCCCCACCCT
R: CTGACCCTTTCTGAGA
rKCNQ4 AF249748 F: GGTGGATGATGTCATGC
R: ACCCTTATCGCCCTTCT
rKCNQ5 XM237012 F: CTCAAAACCGTCATCC
R: GTCTCGTGTTCTGCTGT
rGAPDH NM_017008 F: TCTGACATGCCGCCTGG
R: CACCACCCTGTTGCTG
Table specifies forward (F) and reverse (R) primers used for RT-PCR of KCNQ andwere transferred onto a Hybond-P PVDF transfer membrane (Amersham
Biosciences, 0.45 μm) in 25 mM Tris base, 200 mM glycine, 20% methanol
using a mini transblot (Hercules, CA, USA). After transfer, the membranes were
incubated for 1 h at room temperature in blocking buffer (PBS containing 4%
low-fat milk powder). The membrane was incubated overnight at room
temperature in blocking buffer containing rabbit anti-hKCNQ1 in 1:100 dilution.
After washing, bound antibody was revealed with HRP-conjugated donkey anti-
rabbit antibody (1/10000, Jackson Immunosearch Laboratories, Westgrove, PA,
USA) in blocking buffer for 45 min and detected by enhanced chemilumines-
cence (ECL). Immunoblots were exposed on hyperfilm ECL (Amersham
Biosciences).
2.6. Fluorescence microscopy - F-actin visualization
Neonatal rat cardiomyocytes plated on coverslips were washed with PBS
and then fixed with 1.6% paraformaldehyde in PBS for 15 min at room
temperature. The fixed cells were washed 3×5 min in PBS and incubated with
50 mM NH4Cl in PBS for 20 min. The cells were then washed 1×5 min in PBS
and permeabilized for 20 min in 0.20% Triton X-100 in PBS containing 4%
bovine serum albumin (BSA). This was followed by a single wash (5 min) in
PBS and quenching was performed by 50 min incubation with 4% BSA in PBS.
The cells were then incubated for 45 min with Alexa Fluor 488-labeled
phalloidin (2 U/mL, Molecular Probes, Leiden, the Netherlands). The Alexa
Fluor 488-conjugated phalloidin was kept as a stock solution in methanol.
Immediately before use the methanol was evaporated, and the phalloidin was
dissolved in PBS with 4% BSA. Following the incubations the cells were
washed 2×5 min in PBS with 4% BSA followed by 3×5 min in PBS. The
coverslips were mounted in Prolong Antifade (Molecular Probes, Leiden, the
Netherlands).
2.7. Chemicals
Unless otherwise indicated, all chemicals and compounds were from Sigma-
Aldrich (Sigma-Aldrich, St. Louis, MO, USA).
2.8. Statistics
The data are presented as individual experiments representative of at least 3
independent experiments, or as mean±SEM. Statistical significance was tested
using two-tailed Student's t-test, p<0.05 was considered significant.Size [bp] Ref.
TTC 218 [13]
GATG [13]
ACAAC 210 [13]
TGT [13]
TGGT 250 [13]
TCCC [13]
AAGTC 162 [24]
CCTG –
TCAAGGTCATC 239 [25]
CGGTCTTTGCTCTT [25]
GCCTCAAAGTCAGC 233 [25]
TTGTCCGTTATTG [25]
AAAGGCTGCCA 239 [25]
CTTCTTATGTTTTGGAGTGGAT [25]
CTGCTGTGAAGA 242 [25]
CCCGAGTCTTG [27]
GAGCCATCAGAATCA 234 [25]
TATTTTCTCTCGGCTCTT [25]
AGAAACCTGC 243 [25]
TAGCCATATTCATTGTC [25]
KCNE subunits and GAPDH; r=rat.
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3.1. Hypoosmotic cell swelling and RVD response of neonatal
rat cardiomyocytes
The effect of hypoosmotic exposure on neonatal cardiomyo-
cytes was investigated using calcein as cytosolic marker and
confocal microscopy. As expected, exposure to hypoosmotic
Tyrodes buffer (0.67 TB) led to an increase in cell volume,
reflected as an increase in cell height. Fig. 1 shows an images of a
neonatal rat cardiomyocyte during perfusion with isoosmotic
(TB, Fig. 1A), hypoosmotic TB (0.67 TB, Fig. 1B) and after
reperfusion with isoosmotic solution (TB, Fig. 1C). The images
illustrate the reversible increase in cell volume, observed during
hypoosmotic exposure. The image in Fig. 1B of the neonatal rat
cardiomyocyte exposed to hypoosmotic TB was taken at the time
ofmaximal cell swelling, in the presented experiment 80 s after the
onset of hypoosmotic exposure. The hypoosmotic exposure was
terminated after ≈10 min and the cell was returned to isoosmotic
TB. The image shown in Fig. 1C is taken 60 s after the cell was
returned to isoosmotic conditions. The cardiomyocyte responded
to reperfusion with isoosmotic TB with a decrease in cell volume
to a value below the initial cell volume as expected after the loss of
osmolytes and water during RVD. Cells superfused with
isoosmotic TB showed no change or a very small decrease in
cell volume under isoosmotic conditions for the duration of the
experiments (approximately 30 min, data not shown).Fig. 1. Measurement of cardiomyocyte volume using confocal microscopy. Primary r
volume were followed using confocal microscopy as described inMaterials and metho
in extracellular osmolarity. (B) The image is taken at the time of maximal cell swellin
exposure was terminated after ≈10 min and the cell was returned to isoosmotic TB
conditions. The data are from a single experiment representative of 8 experiments. (
measured over time (images were collected every 20 s). The neonatal rat cardiomyocy
the open bar) and relative cell volume as a function of time was calculated as desc
reexposure to isoosmotic TB. The data are from a single experiment representative of
channel inhibitor, XE-991. A summary of the average rate of RVD is shown. The ra
methods. The figure shows the average rate of RVD (min−1) under control conditions
10 or 100 μM XE-991 (n=7 and n=5, respectively), please see Results for values.Cell volume changes were followed using x–z scans to collect
cross-sectional images over time. Fig. 1D depicts the relative cell
volume, calculated as the cross-sectional area at time t relative to
the area under isoosmotic conditions. The data shown in Fig. 1D
are from the same experiment illustrated in Fig. 1A–C. Fig. 1D
reveals that the neonatal rat cardiomyocyte responded to
hypoosmotic exposure by a rapid swelling followed by a RVD
response. The RVD responsewas biphasic, consisting of an initial
fast and linear part, followed by a slower volume recovery. In
calculating the rate of RVD we used the initial, linear part of the
RVD response. The maximal cell volume during exposure to a
solution with 0.67 the normal osmolarity was 1.20±0.01 (n=8)
relative to isoosmotic control. Asweweremainly interested in the
initial rate of RVD, the RVD response was not followed for more
than approximately 10 min to reduce photodamage to the cells
and the RVD response was therefore not complete. Upon
reperfusion with isoosmotic TB, the neonatal rat cardiomyocyte
showed a rapid reduction in cell volume to a level below the initial
value. This reduced volume in isoosmotic TB can be explained
by loss of cell osmolytes and water during the RVD response,
which causes the isoosmotic TB to be hypertonic to the cell.
3.2. XE-991 inhibits the RVD response in neonatal rat
cardiomyocytes
The voltage-gated KCNQ1 channels, which are present in
the heart, have been shown to be activated by cell swelling (seeat neonatal cardiomyocytes were loaded with calcein and changes in relative cell
ds. (A) The cardiomyocyte is shown under isoosmotic conditions before changes
g (80 s after onset of the hypoosmotic exposure, 0.67 TB). (C) The hypoosmotic
. The image shown in C is taken 60 s after the cell was returned to isoosmotic
D) RVD response after hypoosmotic cell swelling. The cross-sectional area was
te was exposed to hypoosmotic TB with 0.67 the normal osmolarity (indicated by
ribed in Materials and methods. The hypoosmotic exposure was terminated by
8 experiments. (E) The RVD response was reduced in the presence of the KCNQ
te of RVD was calculated using linear regression as described in Materials and
(0.67 hypoosmotic TB without drug, n=8) and under conditions with addition of
The data are given as mean±SEM.
Fig. 2. The effect of hypoosmotic cell swelling and XE-991 on the membrane
potential and APD of primary neonatal rat cardiomyocytes. (A) Hypoosmotic
swelling of the cardiomyocytes resulted in a hyperpolarization of the resting
membrane potential by 9.5±1.2 mV. Application of XE-991 (10 μM) reduced
this shift in the resting membrane potential significantly (p<0.002, unpaired
t-test) to 5.7±0.8 mV. (B) Hypoosmotic swelling of the neonatal rat
cardiomyocytes increased the APD by 21±15 ms (not significant, n=5). In the
presence of XE-991 the APD was significantly increased; under isoosmotic
conditions the APD was 584±34 and during hypoosmotic cell swelling the
action potential duration was prolonged by 158±24 ms (n=4). The prolongation
of the APD during hypoosmotic swelling in the presence of XE-991 compared to
control was significant (p<0.006, unpaired t-test).
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channels in the neonatal rat cardiomyocyte RVD response we
examined the effect of the KCNQ-inhibitor XE-991 on the rate
of RVD. The degree of cell swelling, i.e. the maximal increase
in relative cell volume during hypoosmotic exposure, was not
significantly different in cells treated with XE-991 (10 or
100 μM) as compared to controls without inhibitor; the maximal
cell swelling was 1.20±0.07 (n=8) in control cells, 1.20±0.10
(n=7) and 1.14±0.04 (n=5) in cells treated with 10 or 100 μM
XE-991, respectively. To specify the effect of XE-991 on the
initial RVD response, we calculated the average initial rate of
RVD in neonatal rat cardiomyocytes after maximal cell swelling
using linear regression. XE-991 significantly reduced the rate of
RVD (by 50%) both at 10 and 100 μM (Fig. 1E), the average
rate of RVD is −0.014±0.002 min−1 (n=8) under control
hypoosmotic conditions, −0.007±0.002 min− 1 (n=7) in the
presence of 10 μM XE-991 and −0.006±0.004 min− 1 (n=5)
with 100 μM XE-991. This demonstrates that an XE-991
sensitive current plays an important role in the RVD response in
neonatal rat cardiomyocytes.
3.3. The effect of hypoosmotic cell swelling and XE-991 on the
electrophysiological properties of neonatal rat cardiomyocytes
To assess the effect of hypoosmotic cell swelling on the
electrophysiological properties of the neonatal rat cardiomyo-
cytes, measurements of membrane potential (Vm) were
conducted using patch-clamp. As shown in Fig. 2A, hypoos-
motic swelling of the neonatal rat cardiomyocytes resulted in a
hyperpolarization of 9.5±1.2 mV, from −67.9±2.2 mV (n=5)
to −77.4±2.7 mV (n=5). Hyperpolarization was expected since
a 1/3 reduction of K+ would shift the equilibrium potential for
K+ by approximately −10 mV. Application of XE-991 (10 μM)
reduced the shift in the resting membrane potential during
hypoosmotic challenge; before cell swelling the resting
membrane potential was −67.3±3.0 mV in the presence of
XE-991 and during hypoosmotic challenge in the presence of
XE-991, the membrane potential was only hyperpolarized by
5.7±0.8 mV to −73.1±3.3 mV (n=4). This hyperpolarization
was significantly lower than in controls (p<0.002), indicating
that XE-991 sensitive channels are activated during swelling.
Hypoosmotic swelling of the neonatal rat cardiomyocytes did
not significantly affect action potential duration (APD) deter-
mined as the time to repolarization to the diastolic interval
+10 mV (Fig. 2B). On average APD increased by 21±15 ms,
from 412±67 ms to 433±61 ms (n=5). However, in the
presence of XE-991, APD was significantly increased, both
under isoosmotic conditions (+61.5±11.1 ms), where the APD
was 584±34 and during hypoosmotic cell swelling, where the
APD was prolonged by 158±24 ms to 742±27 (n=4). These
results clearly demonstrate the presence of an XE-991 sensitive
current that hyperpolarizes the membrane potential during
hypoosmotic cell swelling and prevents prolongation of the
action potential duration.
To investigate the XE-991 sensitive currents further, whole-
cell currents were measured in neonatal rat cardiomytes during
voltage-clamp. Fig. 3A showsmembrane currents recorded froma neonatal rat cardiomyocyte before and during application of
XE-991 (10 μM). Depolarization of the membrane to +20 mV
revealed a transient outward current followed by a sustained
outward current during maintained depolarization. The XE-991
sensitive component of the current appeared to be either very fast
activating or time-independent.
In the voltage-clamp experiments, the isoosmotic solution
contained mannitol and hypoosmotic cell swelling was induced
by decreasing mannitol from 100 mM to 50 mM. Thereby the
ionic concentrations were unaffected. The time-course of
whole-cell currents measured at +20 mV was followed before
and during hypoosmotic cell swelling, a representative example
of experiments conducted on four different cells is depicted in
Fig. 3B. Perfusion with hypoosmotic solution increased
outward whole-cell currents. This increase in current persisted
throughout the experiment (>8 min). Application of XE-991
(10 μM) reduced the swelling activated current (Fig. 3C). The
results are summarized in Fig. 3D: hypoosmotic cell swelling
significantly increased whole-cell currents from 710±205 pA
(n=7) to 2092±360 pA (n=7). The difference of 1382.0±
414 pA is statistically significant (p=0.0018, n=7, paired
t-test). Application of XE-991 (10 μM) to the hypoosmotic
solution reduced the swelling induced current by 573±470 pA,
from 2092±360 pA (n=7) to 1519±303 (n=7). The reduction
is statistically significant (p=0.0032, n=7, paired t-test).
Fig. 3. The effect of hypoosmotic cell swelling and XE-991 on the electrophysiological properties of primary neonatal rat cardiomyocytes. (A) Representative whole-
cell currents measured in a neonatal cardiomyocytes perfused with isoosmotic ringer. Currents were elicited by clamping the neonatal cardiomyocyte membrane to the
protocol shown in the insert (values are in mV). Application of XE-991 (10 μM) revealed an XE-991 sensitive component. (B) Representative time-course
measurements of whole-cell currents before and during hypoosmotic cell swelling (indicated by white bar). The same protocol as in panel Awas used. Currents were
measured at + 20 mVas indicated by the arrow in the insert). (C) As in panel B. During hypoosmotic cell swelling XE-991 was applied (10 μM, indicated by black bar).
(D) Summary of whole-cells currents measured in isoosmotic, hypoosmotic and hypoosmotic+XE-991 as described for panels B and C. In isotonic solution the mean
current was 710±205 pA (n=7), during hypoosmotic cell swelling the current increased to 2092±360 pA (n=7). The difference of 1382±414 pA is statistically
significant (p=0.0018, n=7, paired t-test). Application of XE-991 in hypoosmotic solution reduced the swelling induced current by 573±471 pA, from 2092±360 pA
(n=7) to 1519±303 (n=7). The reduction is statistically significant (p=0.0032, n=7, paired t-test). Data are given as mean±SEM.
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cardiomyocytes
The expression of KCNQ1–5 and KCNE1–4 subunits in
neonatal rat cardiomyocytes was investigated by non-quantita-
tive RT-PCR using RNA isolated from neonatal rat heart and
neonatal rat cardiomyocytes cultured for 6 days. We found that
KCNQ1 and KCNE1 were present in both preparations; none of
the other KCNQ and KCNE subunits could be detected under
the reaction conditions used. To confirm the presence of the
KCNQ1 protein in the neonatal rat cardiomyocytes employed in
the present study, Western blot analysis was performed (Fig. 4).
The antibody recognized an immunoreactive band at about
70 kDa in extracts of neonatal rat cardiomyocytes. This fits well
with the expected molecular weight for a KCNQ1 monomer. A
similar band was detected in COS cells transfected with
KCNQ1 and in CHO cells transfected with flag-tagged
hKCNQ1, but not in untransfected, wildtype COS cells.
Interestingly, the antibody also recognized a strongly immunor-
eactive band at approximately 160 kDa in lysates of transfected
CHO cells, which was to a lower extent also detected in extracts
of neonatal rat cardiomyocytes and probably represents a
multimeric state of the KCNQ1 channel protein. In the lysates
of transfected cells, two more distinct bands at high molecular
weight could be detected. Similar bands were detected in CHO
cells transfected with flag-tagged KCNQ1 employing anti-flag
antibody (data not shown).3.5. Potential role for changes in F-actin structure
To investigate whether the F-actin cytoskeleton plays a
potential role in the response to osmotic challenges as has been
suggested for a number of ion channels, we investigated if
qualitative changes in F-actin could be observed during hypo-
osmotic exposure.
F-actin was visualized using fluorophore-conjugated phal-
loidin (Alexa488-phalloidin) and confocal microscopy. The
neonatal rat cardiomyocytes were treated with isoosmotic or
hypoosmotic (0.67) TB (see Materials and methods). Fig. 5
shows cells from a typical experiment and illustrates that
hypoosmotic exposure led to changes in the structure of the F-
actin cytoskeleton. Under isoosmotic conditions parallel
bundles of actin fibers running throughout the cells were seen
(Fig. 5A). During hypoosmotic treatment, the cells changed to a
more rounded shape, the F-actin fibers were less pronounced
and small patches of F-actin appeared, even though cells with
no apparent change in F-actin structure were present as well
(Fig. 5B). We also tested if XE-991 affected the integrity of the
actin cytoskeleton under isoosmotic conditions, but there was
no apparent change in the appearance of the F-actin (data not
shown).
Whether changes in the structure of the F-actin cytoskeleton
affected the rate of the RVD response was further investigated by
exposing the neonatal rat cardiomyocytes to CD, a drug that
disrupts the structure of the F-actin cytoskeleton. Fig. 4C
Fig. 4. Expression of KNCQ and KCNE subunits in neonatal rat heart. (A) RT-PCR analysis of the expression of KCNQ (Q) and KCNE (E) subunits in neonatal rat
heart. M=DNA mass markers. (B) RT-PCR analysis of the expression of KCNQ and KCNE subunits in cultures of neonatal rat cardiomyocytes. (C) Immunoblot
analysis of KCNQ1 expression in neonatal rat cardiomyocytes. Whole cell lysates of wild type, non-transfected COS-1 cells (1), COS-1 cells expressing human
KCNQ1 (2), CHO cells expressing N-terminally flag-tagged human KCNQ1 (3), and rat cardiac myocytes (4) were subjected to Western blotting and examined for
KCNQ1 expression. Arrows indicate bands at approximately 70 kDa and 160 kDa. Note the slightly increased size of the flag-tagged protein.
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treatment and shows prominent disruption of the F-actin
cytoskeleton. Treatment with CD (1 μM) significantly inhibited
the rate of RVD in these cells (Fig. 5D), from −0.014±
0.002 min−1 (n=8) under control conditions to −0.001±Fig. 5. Changes in F-actin cytoskeleton during hypoosmotic or CD exposure. Neona
(B) or 1 μMCD for 5 min followed by fixation, staining with Alexa-488 phalloidin a
and methods. The images are from a single experiment, representative of 3 experimen
RVD during hypoosmotic exposure, under control conditions (0.67 TB without additi
is shown. Please see Results for values. The data are given as mean±SEM.0.002 min−1 (n=5) in cells treated with CD. The maximal cell
swelling during hypoosmotic exposure in cells treated with CD
was not significantly different from untreated controls; 1.16±
0.08 (n=5) compared to 1.20±0.07 (n=8) under control
conditions.tal rat cardiomyocytes were treated with isoosmotic (A), hypoosmotic (0.67) TB
nd visualization of F-actin using a confocal microscope as described in Materials
ts. The scale bar is 10 μM. (D) CD inhibits the RVD response. The average rate of
on of drug, n=8) or in the presence of 1 μMCD (hypoosmotic TB with CD, n=5
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Patch-clamp studies have shown that osmotic induced
swelling of guinea-pig cardiomyocytes results in a prominent
increase in IKs [7]. These results indicate that KCNQ1 could
potentially be implicated in the RVD response of cardiomyo-
cytes; however, the effect of enhancing KCNQ1 current on the
actual cell-volume of the cardiomyocytes has to our knowledge
not previously been investigated.
4.1. The rate of the RVD response in neonatal rat
cardiomyocytes is reduced by the KCNQ-blocker XE-991
The primary, neonatal rat cardiomyocytes in the present study
responded to hypoosmotic exposure by rapid cell swelling,
primarily seen as an increase in cell height and the cell swelling
was followed by an RVD response. We found that the rate of the
RVD was reduced by approximately 50% by the KCNQ blocker
XE-991 (Fig. 1E), suggesting that activation of KCNQ1
channels during hypoosmotic cell swelling is indeed important
for the RVD in isolated neonatal rat cardiomyocytes. In
consistence with the previous studies on guinea-pig ventricular
cardiomyocytes, patch-clamp experiments on the isolated neo-
natal rat cardiomyocytes confirmed the presence of an XE-991
sensitive current that activated during hypoosmotic cell swelling
(Figs. 2 and 3). Current-clamp experiments revealed that the XE-
991 sensitive current caused hyperpolarization of the cardio-
myocyte membrane potential and prevented prolongation of the
APD (Fig. 2). These observations are in agreement with previous
work on guinea-pig ventricular cardiomyocytes, where it has
been shown that hypoosmotic cell swelling initially leads to a
prolongation of the APD followed by a shortening of the cardiac
APD after a few minutes [27,28]. This shortening of the APD
was prevented by application of KCNQ channel inhibitors [27].
Voltage-clamp experiments demonstrated that hypoosmotic
cell swelling resulted in a significant increase of outward whole-
cell current and application of XE-991 inhibited a significant
part of this swelling induced current. XE-991 is generally
accepted to be a specific blocker of the KCNQ potassium
channels and all members of the KCNQ family, KCNQ1–5, are
sensitive to XE-991. The IC-50 values for XE-991's effect on
the KCNQ1, KCNQ2, KCNQ3, KCNQ4 and KCNQ5 channels
are 0.8 μM, 0.7 μM, <50 μM, 5.5 μM and 61 μM, respectively
[29–31]. We tested the effect of XE-991 on the IKr current and
found that when used at concentrations below 100 μM, XE-991
has very little effect on IKr (Elmedyb et al., in press [32]).
4.2. The KCNQ1 channels are present in neonatal rat
cardiomyocytes
The functional role of the KCNQ1 channels in rat
cardiomyocytes is controversial. However, KCNQ1 protein as
well as KCNQ1 mediated currents have been reported in adult
rat cardiomyocytes [33,34]. KCNQ2 and KCNQ2 channels are
normally considered to be neuronal but mRNA encoding
KCNQ4 and KCNQ5 have been detected in cardiac tissue
[34,35]. Both KCNQ4 and KCNQ5 channels are highly sen-sitive to changes in cell volume when heterologously expressed
[10,36], but amounts of KCNQ4 and −5mRNA in cardiac tissue
are small compared to that of KCNQ1 [35] and the presence of
KCNQ4 and KCNQ5 has not been confirmed at protein level. In
our preparation of neonatal rat cardiomyocytes as well as in
neonatal rat heart only KCNQ1 and KCNE1 subunits were
present at the RNA level and all other KCNQ and KCNE
subunits investigated were absent. The presence of KCNQ1
protein was confirmed usingWestern blotting (Fig. 4). The band
observed at approximately 70 kDa corresponds to the reported
molecular mass of the full-length KCNQ1 monomer of
approximately 68 kDa [33,37] whereas the observed band at
175 kDa is likely to represent KCNQ1 multimers, as also
observed by Dedek and Waldegger [37], who reported a band at
68 kDa as well as two bands at higher molecular weights,
approximately 160–180 kDa. CD treatment of the neonatal rat
cardiomyocytes prior to solubilization had no effect (data not
shown). This suggests that the XE-991 sensitive current that
accounts for 50% of the rate of the initial part of the RVD
response is mediated by the KCNQ1 channel.
mRNA encoding all members of the KCNE family
(KCNE1–5) have previously been detected in cardiac tissue
of other species including adult rats [35,36] but in our RT-PCR
experiments only RNA encoding the KCNE1 subunit was
detected. Recently, the KCNQ1, KCNE1 as well as KCNE2
proteins were found in adult rat cardiomyocytes by Wu et al.
[34] and Jiang et al. [38] and shown to co-localize at the surface
membrane and in T-tubules, possible in a tripartite complex
[34]. It has been suggested that KCNE subunits may participate
in a dynamic regulation of the KCNQ1 channel [34,39,40]. We
speculate that developmental changes may account for the
absence of KCNE2 RNA in our experiments sinceWu et al. [34]
and Jiang et al. [38] used adult animals for their experiments
while we isolated material from neonate rats.
The IC50 value for XE-991 depends on the association with
KCNE subunits; the reported IC50 value for KCNQ1 alone was
0.8 μM, whereas it was 11 μM for KCNQ1 in complex with
KCNE1 [41]. Since the inhibition of the RVD response in the
present studywas equally efficient using 10 or 100μM, this could
suggest that the KCNQ1 channels involved in the RVD response
were not in complex with KCNE1. Further, the XE-991 sensitive
current observed in the voltage-clamp experiments appeared to
be very fast activating suggesting that the RVD response of
cultured neonatal rat cardiomyocytes is mediated by KCNQ1
subunits acting alone, despite the presence of mRNA encoding
KCNE1. In heterologous expression systems it has previously
been demonstrated that the presence of KCNE1 did not change
the sensitivity of KCNQ1 to changes in cell volume [10].
4.3. The RVD response of isolated neonatal rat cardiomyocytes
required an intact F-actin cytoskeleton
Hypoosmotic cell swelling has been reported to cause
changes in the F-actin structure and/or content. Generally a
decrease in F-actin content is seen [16,22,42], but reorganization
of F-actin with no quantitative change [17], no apparent change
in content or structure [43], as well as a transient, swelling-
772 K. Calloe et al. / Biochimica et Biophysica Acta 1773 (2007) 764–773induced increase in F-actin content has been reported [20]. In
the present study we found that cell swelling changed the
structure of the F-actin cytoskeleton of the neonatal rat
cardiomyocytes. Hypoosmotic exposure caused a disruption
of actin stress fibers, appearance of slight patches of actin and a
more rounded cell shape (Fig. 5A and B). It should be noted that
a few cells showed no clear change in F-actin structure during
hypoosmotic exposure.
For KCNQ1 channels expressed in Xenopus laevis oocytes
the swelling-induced activation of the KCNQ1 current was
abolished after disruption of the structure of the F-actin
cytoskeleton using CD [10]. In agreement with these observa-
tions, disruption of the structure of the F-actin cytoskeleton in
neonatal rat cardiomyocytes with CD almost completely
inhibited the RVD response (Fig. 4C and D).
Treatment with CD causes inhibition of swelling-activated
ion transport for numerous channels [10,16,22,42,44] suggest-
ing that rearrangement of the cytoskeleton may be commonly
involved in volume-sensing, although exceptions are known [4].
Other factors have been investigated and it has been shown that
the swelling-induced increase in IKs current in isolated guinea-
pig cardiomyocytes is independent of the intracellular Ca2+
concentration [6,7] and unaffected by protein kinase A and C
(PKA and PKC) inhibitors or activators [6,12]. These observa-
tions have been confirmed on heterologously expressed KCNQ1
channels [10,12]. A recent study has indicated a role for tyrosine
kinase in increasing the IKs current during hypoosmotic cell
swelling in guinea-pig cardiomyocytes [12]. However, inhibi-
tion or activation of protein tyrosine kinases did not affect the
swelling induced current of heterologously expressed KCNQ1/
KCNE1 [11]. In rat hepatocytes it has been reported that an
increase in phosphatidylinositol 4,5-bisphosphate levels acti-
vates KCNQ1-like channel, probably KCNQ1 in a complex with
KCNE3, by cytoskeletal rearrangements in a PKC dependent
manner [45]. Though it seems plausible that the cytoskeleton is
involved in transmitting volume changes to changes in current,
the exact mechanism remains elusive.
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